Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$651M |
| 2 |
Charter Communications
CHTR
|
+$643M |
| 3 |
Parker-Hannifin
PH
|
+$606M |
| 4 |
Goldman Sachs
GS
|
+$534M |
| 5 |
FedEx
FDX
|
+$376M |
Top Sells
| 1 |
Biogen
BIIB
|
+$701M |
| 2 |
American Tower
AMT
|
+$665M |
| 3 |
Nike
NKE
|
+$595M |
| 4 |
AGN
Allergan plc
AGN
|
+$569M |
| 5 |
McDonald's
MCD
|
+$556M |
Sector Composition
| 1 | Technology | 18.72% |
| 2 | Consumer Discretionary | 17.48% |
| 3 | Healthcare | 13.38% |
| 4 | Communication Services | 12.13% |
| 5 | Financials | 11.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MPG
476
DELISTED
Metaldyne Performance Group Inc.
MPG
| $9.98M | 0.01% |
434,939
-78,184
| -15% | -$1.79M |
|
477
Turning Point Brands
TPB
$1.77B
| $9.63M | 0.01% |
786,141
-124,224
| -14% | -$1.52M |
|
478
Chemours
CC
$2.44B
| $9.48M | 0.01% |
429,042
-64,603
| -13% | -$1.43M |
|
479
Norfolk Southern
NSC
$61.1B
| $9.34M | 0.01% |
86,452
+26,474
| +44% | +$2.86M |
|
|
ENLK
480
DELISTED
EnLink Midstream Partners, LP
ENLK
| $9.06M | 0.01% |
491,717
+299,641
| +156% | +$5.52M |
|
|
GNMX
481
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $8.91M | 0.01% |
1,720,838
+4,988
| +0.3% | +$25.8K |
|
|
AVXS
482
DELISTED
AveXis, Inc. Common Stock
AVXS
| $8.77M | 0.01% |
183,786
+641
| +0.3% | +$30.6K |
|
483
Marcus & Millichap
MMI
$1.26B
| $8.77M | 0.01% |
328,230
+6,229
| +2% | +$166K |
|
484
Energy Transfer Partners
ET
$59.8B
| $8.69M | 0.01% |
449,795
+52,561
| +13% | +$1.02M |
|
485
BioCryst Pharmaceuticals
BCRX
$1.68B
| $8.58M | 0.01% |
1,355,100
+3,770
| +0.3% | +$23.9K |
|
486
Berkshire Hathaway Class B
BRK.B
$1.06T
| $8.49M | 0.01% |
52,096
+30,691
| +143% | +$5M |
|
487
Johnson & Johnson
JNJ
$423B
| $8.48M | 0.01% |
73,632
+45,875
| +165% | +$5.29M |
|
|
PETX
488
DELISTED
Aratana Therapeutics, Inc.
PETX
| $8.24M | 0.01% |
1,146,927
-75,080
| -6% | -$539K |
|
489
Corvus Pharmaceuticals
CRVS
$442M
| $8.15M | 0.01% |
570,201
+874
| +0.2% | +$12.5K |
|
490
Clearway Energy Class A
CWEN.A
$3.18B
| $8.08M | 0.01% |
525,694
-626,525
| -54% | -$9.62M |
|
|
ETP
491
DELISTED
Energy Transfer Partners, L.P.
ETP
| $7.39M | 0.01% |
307,692
-207,482
| -40% | -$4.98M |
|
|
DSCI
492
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $7.35M | 0.01% |
1,412,577
+2,909
| +0.2% | +$15.1K |
|
493
Agios Pharmaceuticals
AGIO
$2.07B
| $7.09M | 0.01% |
169,799
+547
| +0.3% | +$22.8K |
|
494
USA Compression Partners
USAC
$2.84B
| $6.97M | 0.01% |
403,048
+35,859
| +10% | +$620K |
|
495
Verizon
VZ
$183B
| $6.93M | 0.01% |
129,903
+71,248
| +121% | +$3.8M |
|
496
Intel
INTC
$116B
| $6.3M | 0.01% |
173,702
+82,722
| +91% | +$3M |
|
497
Spyre Therapeutics
SYRE
$977M
| $6.29M | 0.01% |
57,829
+831
| +1% | +$90.4K |
|
498
iRhythm Technologies
IRTC
$5.85B
| $6.16M | 0.01% |
+205,294
| New | +$6.16M |
|
|
TRHC
499
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $6.07M | 0.01% |
405,194
+135,529
| +50% | +$2.03M |
|
500
Terex
TEX
$3.45B
| $5.93M | 0.01% |
+188,015
| New | +$5.93M |
|